|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3033 USD | -3.71% |
|
+2.85% | -27.09% |
| 05-14 | Earnings Flash (INM) INMED PHARMACEUTICALS Posts Q3 Revenue $1.2M | MT |
| 05-14 | InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
InMed Pharmaceuticals Inc. reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was USD 1.09 million. Net loss was USD 18.6 million compared to USD 10.2 million a year ago.
Basic loss per share from continuing operations was USD 33.17 compared to USD 37.96 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.09% | 1.92M | |
| +12.30% | 118B | |
| +12.15% | 106B | |
| -8.14% | 23.4B | |
| -1.69% | 21.78B | |
| -10.60% | 18.09B | |
| -41.25% | 16.72B | |
| -15.33% | 15.97B | |
| +5.80% | 14.03B | |
| +28.03% | 11.67B |
INMED PHARMACEUTICALS INC. 
